{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:48:29Z","timestamp":1787060909484,"version":"build-2736575974"},"reference-count":13,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ad.2024.05.008","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T15:16:25Z","timestamp":1716909385000},"page":"T647-T653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["[Translated article] Comparing the Use of Topical Therapy Along with Anti-IL-17 and Anti-IL-23 to Treat Moderate-to-Severe Psoriasis in the Routine Clinical Practice"],"prefix":"10.1016","volume":"115","author":[{"given":"S.","family":"Berenguer-Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Romero-D\u00e1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Aparicio-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Olivares-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Daud\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Llamas-Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2024.05.008_bib0070","doi-asserted-by":"crossref","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ."},{"key":"10.1016\/j.ad.2024.05.008_bib0075","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ad.2017.07.002","article-title":"Psoriasis moderada. Propuesta de definici\u00f3n","volume":"108","author":"Llamas-Velasco","year":"2017","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2024.05.008_bib0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ad.2021.10.003","volume":"113","author":"Carrascosa","year":"2022","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2024.05.008_bib0085","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s40257-014-0089-1","article-title":"Biologic Therapy with or Without Topical Treatment in Psoriasis: What Does the Current Evidence Say?","volume":"15","author":"Jensen","year":"2014","journal-title":"Am J Clin Dermatol."},{"key":"10.1016\/j.ad.2024.05.008_bib0090","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cpt.893","article-title":"Anti-IL-23 and Anti-IL-17 Biologic Agents for the Treatment of Immune-Mediated Inflammatory Conditions","volume":"103","author":"Frieder","year":"2018","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.ad.2024.05.008_bib0095","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1365-2133.2003.05173.x","article-title":"The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial","volume":"148","author":"de Jong","year":"2003","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2024.05.008_bib0100","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2340\/00015555-0585","article-title":"Effect of calcipotriol on etanercept partial responder psoriasis vulgaris and psoriatic arthritis patients","volume":"89","author":"Campione","year":"2009","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.ad.2024.05.008_bib0105","first-page":"e310","article-title":"Benefit of a topic ointment as co-medication with biologic drugs for the management of moderate-severe psoriasis: a prospective, observational real-life study","volume":"171","author":"Bernardini","year":"2020","journal-title":"Clin Ter."},{"key":"10.1016\/j.ad.2024.05.008_bib0110","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s13555-020-00454-z","article-title":"Adjunctive Use of Calcipotriene\/Betamethasone Dipropionate Foam in a Real-World Setting Curtails the Cost of Biologics Without Reducing Efficacy in Psoriasis","volume":"10","author":"Bagel","year":"2020","journal-title":"Dermatol Ther (Heidelb)."},{"key":"10.1016\/j.ad.2024.05.008_bib0115","first-page":"918","article-title":"Treat to Target in Psoriasis: A Real-World Experience With Biologics and Adjunctive Topical Therapy","volume":"17","author":"Bagel","year":"2018","journal-title":"J Drugs Dermatol."},{"key":"10.1016\/j.ad.2024.05.008_bib0120","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/1203475415604322","article-title":"Predictors of topical use in psoriasis patients in the REFINE study","volume":"20","author":"Gooderham","year":"2016","journal-title":"J Cutan Med Surg."},{"key":"10.1016\/j.ad.2024.05.008_bib0125","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/bjd.13087","article-title":"\u00abHappy\u00bb drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network","volume":"171","author":"Van den Reek","year":"2014","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2024.05.008_bib0130","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2340\/00015555-2011","article-title":"Treatment satisfaction of patients with psoriasis","volume":"95","author":"Schaarschmidt","year":"2015","journal-title":"Acta Derm Venereol."}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731024004290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731024004290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T20:41:01Z","timestamp":1719780061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731024004290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0001731024004290"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2024.05.008","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Comparing the Use of Topical Therapy Along with Anti-IL-17 and Anti-IL-23 to Treat Moderate-to-Severe Psoriasis in the Routine Clinical Practice","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2024.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2023.12.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}